Triage^® Meters

Triage Meters are designed to provide diagnostic results quickly and easily. Quantitative diagnostic panel results are displayed and printed in easy to read numbers and highlighted when the result is above the cutoff. Qualitative diagnostic panel results are displayed as positive (POS) or negative (NEG), eliminating the need for interpretation of lines that often hamper qualitative diagnostics.

Cardiovascular Diseases

• Triage BNP Test
  An immunoassay that measures B-type Natriuretic Peptide (BNP) in whole blood or plasma, used as an aid in the diagnosis and assessment of severity of heart failure. The test is also used for the risk stratification of patients with acute coronary syndromes.
• Triage Cardiac Panel
  An immunoassay for the quantitative determination of CK-MB, myoglobin, and troponin I in whole blood or plasma, as an aid in the diagnosis of acute myocardial infarction.
• Triage CardioProfilER
  An immunoassay for use as an aid in the diagnosis of acute myocardial infarction, the diagnosis and assessment of severity of congestive heart failure, and the risk stratification of patients with acute coronary syndromes. One panel combines high-sensitivity troponin I, CK-MB, myoglobin, and BNP to provide rapid, accurate results in whole blood and plasma.
• Triage Profiler S.O.B.
  An immunoassay for use as an aid in the diagnosis of myocardial infarction, the diagnosis and assessment of severity of heart disease, the assessment and evaluation of patients suspected of having disseminated intravascular coagulation and thromboembolic events including pulmonary embolism and DVT, and the risk stratification of patients with acute coronary syndromes.
• Triage D-Dimer Test
  An immunoassay for use as an aid in the assessment and evaluation of patients suspected of having disseminated intravascular coagulation or thromboembolic events including pulmonary embolism (PE) and DVT.

Drug Screening

• Triage TOX Drug Screen
  A fluorescence immunoassay intended to be used with the Triage Meters for the point-of-care qualitative determination of major metabolites of amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, opiates, phencyclidine, THC and trycylic antidepressants in urine.